Applied Therapeutics Inc.

NASDAQ: APLT · Real-Time Price · USD
0.53
0.02 (3.01%)
At close: Aug 26, 2025, 3:59 PM
0.52
-2.59%
After-hours: Aug 26, 2025, 06:14 PM EDT

Applied Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-67.74M -43.51M -105.62M -187.31M -161.09M -193.56M -119.76M -96.51M -73.24M -69.52M -82.51M -95.24M -104.56M -104.53M -105.58M -102.11M -103.54M -105.77M
Depreciation & Amortization
618K 631K 647K 573K 366K 360K 354K 462K 456K 449K 443K 436K 428K 423K 415K 407K 398K 387K
Stock-Based Compensation
12.79M 12.57M 13.47M 7.99M 7.73M 7.68M 7.36M 7.73M 8.75M 9.14M 9.16M 10.01M 9.8M 10.27M 11.18M 10.88M 10.64M 9.68M
Other Working Capital
4.05M -1.18M 2.79M 4.87M -4.1M -90K 1.35M -2.17M -1.17M -3.87M -3.92M -9.29M -2.87M -580K -5.15M -5.09M 994K 8.98M
Other Non-Cash Items
-43.24M -64.71M 1.72M 137.01M 100M 121.8M 58.32M -4.41M -3.66M 3.5M 3.65M 7.14M 6.4M 28K -404K -396K -385K -370K
Deferred Income Tax
n/a n/a n/a -41.8M -14.14M n/a n/a 41.8M 14.14M n/a n/a n/a n/a -990K n/a 2.55M 2.55M 3.54M
Change in Working Capital
5.8M 984K 5.49M 1.7M -6.1M -3.38M -1.44M -3.13M -5.17M -4.24M -8.84M -11.49M 2.51M 1.87M 3.67M 2.13M -1.23M 10.97M
Operating Cash Flow
-91.78M -94.03M -84.31M -81.84M -73.24M -67.09M -55.17M -54.06M -58.73M -60.67M -78.09M -89.14M -85.42M -92.92M -90.73M -86.54M -91.56M -81.57M
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a -27.31M -49.23M -58.22M -64.22M -49.38M -42.03M -39.58M -121.59M -116.22M -211.54M -180.96M
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a 13.87M 34.27M 61.22M 75.74M 77.39M 81.26M 77.41M 86.21M 134.02M 145.29M 184.74M 161.42M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a -6.91M -1.88M 3.65M 13.17M 31.88M 35.38M 46.63M 12.43M 29.07M 37.66M 44.92M
Investing Cash Flow
n/a n/a n/a n/a n/a n/a 13.87M 6.97M 11.99M 17.52M 13.17M 31.88M 35.38M 46.63M 12.43M 29.07M -9.69M -2.43M
Debt Repayment
311K 311K n/a -776K -1.24M -1.55M -1.86M -2.33M -2.79M -3.11M -3.27M -3.52M -3.78M -4.43M -4.72M -1.39M -1.28M n/a
Common Stock Repurchased
1.69M 1.69M 1.69M 1.69M n/a n/a n/a n/a -39K -39K -39K -39K n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
104.44M 104.75M 113.81M 9.37M 19.69M 20.94M 11.89M 11.88M 1.62M 3.15M 3.15M 3.15M 3.21M 4.88M 5.01M 5.96M 5.16M 612K
Financial Cash Flow
n/a -1.69M 113.81M 143.25M 159.82M 190.66M 74.54M 44.16M 26.63M 27.86M 27.69M 27.44M 27.33M 442K 74.72M 78.99M 78.84M 75.56M
Net Cash Flow
-91.78M -95.72M 29.5M 61.41M 86.58M 123.57M 33.24M -2.93M -20.11M -15.3M -37.23M -29.82M -22.71M -45.85M -3.58M 21.53M -22.42M -8.44M
Free Cash Flow
-91.78M -94.03M -84.31M -81.84M -73.24M -67.09M -55.17M -54.06M -58.73M -60.67M -78.09M -89.14M -85.42M -92.92M -90.73M -86.54M -91.56M -81.57M